The researchers found that the rates of
subclinical atherosclerosis progression, as measured by changes in common carotid artery intima - media thickness or coronary artery calcium, did not differ significantly between men assigned to the testosterone or placebo groups.
Research from Keck School of Medicine at the University of Southern California (USC) suggests that hormone therapy, when taken within six years of menopause, may slow the
progression of
subclinical atherosclerosis, the buildup of plaque in the arteries.